Skip to main content
logo
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
27.59
+0.07 (0.25%)
At close: Oct 15, 2026, 4:00 PM EDT
27.42
-0.17 (-0.62%)
After-hours: Oct 15, 2026, 7:30 PM EDT

vTv Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
34349691235467
Market Cap Growth
98.74%445.89%288.02%-56.62%-18.92%-32.00%
Enterprise Value
25639852276493
Last Close Price
27.5939.9913.8111.5026.5139.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.31-89.38-26.7616.63
PB Ratio
4.357.706.36-1.269.254.38
P/TBV Ratio
4.367.707.45---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.95-51.49-31.6923.20

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.01-0.030.120.06
Net Debt / Equity Ratio
-1.10-1.38-2.560.48-1.96-0.83
Net Debt / EBITDA Ratio
9.372.711.520.350.510.63
Net Debt / FCF Ratio
5.173.521.450.470.710.65
Asset Turnover
0.65-0.04-0.070.20
Quick Ratio
12.3513.397.070.911.601.61
Current Ratio
12.4813.547.341.003.521.84
Return on Equity (ROE)
-15.80%-78.94%---238.10%-186.50%
Return on Assets (ROA)
-10.14%-32.00%-61.33%-72.03%-47.99%-62.28%
Return on Capital Employed (ROCE)
-11.50%-39.40%-73.10%-6391.50%-88.30%-118.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.39%-5.44%-20.31%-86.44%-35.48%-19.50%
FCF Yield
-4.89%-5.09%-27.84%-81.45%-29.70%-28.99%
Buyback Yield / Dilution
-74.02%-45.96%-176.79%-8.60%-22.58%-32.90%
SEC Filings: 10-K · 10-Q